Home > News > BioSante Pharmaceuticals Presents New Anthrax Vaccine Data
March 22nd, 2006
BioSante Pharmaceuticals Presents New Anthrax Vaccine Data
Abstract:
Dr. Steve Bell, vice president of research and pre-clinical development for BioSante, will present the new findings in a case study report on the ongoing research and development of a next generation needle-free anthrax (rPA) vaccine using BioVant(TM), the company's patented calcium phosphate (CaP) nanoparticulate technology.
Source:
genengnews.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||